Search results for: 'drug ppps'

Drug device combination products are aimed to provide targeted treatment, enable better drug delivery and improve the efficacy of the device and medicine. This research service (RS) showcases some of these emerging drug-device combination products including drug eluting stents and drug loaded /coated orthopedic implants under implantable drug-devic...

Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies.  Risks due...

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

17 Mar 2022  |  Global  |  Market Research

Global GNSS Downstream Services Growth Opportunities

Future Growth Potential of GNSS Downstream Service Providers due to PPP-RTK and PPP-AR

Infographics

×

Key Issues Addressed

This research service covers the Global Navigation Satellite System (GNSS) Downstream Services market across 17 application areas, such as precision agriculture, survey & mapping, construction, IoT, autonomous driving, autonomous-asset tracking, maritime, rail, airlines, airport, autonomous consumer utilities, consumer devices, UAS, mining, oil and...

09 May 2025  |  Global  |  Market Research

Peripheral Vascular Devices Industry, Global, 2024–2029

Innovations in Drug-eluting Stents and Drug-coated Balloons are Driving Transformational Growth

Infographics

×

Frost & Sullivan observes that the shift to drug-eluting stents and drug-coated balloons will be the key trends driving the peripheral vascular devices industry during the forecast period. Investments in bioresorbable scaffolds will further drive the market growth. Drug-eluting bioresorbable scaffolds are an area of interest among industry stakehol...

Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalabl...

Over the past several decades drug therapies such as analgesics, NSAIDs, and opioids have been used for the effective treatment of different types of acute, chronic, and injury-related pain. Dependence on these drug therapies have led to multiple side effects in human bodies and also addiction towards its consumption. Considering the direct and ind...

The growing interest in drug delivery devices is more towards micro needle technology for vaccines and hormones. As healthcare companies focus on the transdermal mode of delivery for insulin, companies developing patch technologies have also received huge funding, indicating that the interest in the industry is shifting toward transdermal drug deli...